Common Stock, Shares, Outstanding of ENANTA PHARMACEUTICALS INC from 30 Sep 2012 to 31 Dec 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
ENANTA PHARMACEUTICALS INC quarterly Common Stock, Shares, Outstanding in shares history and change rate from 30 Sep 2012 to 31 Dec 2025.
  • ENANTA PHARMACEUTICALS INC Common Stock, Shares, Outstanding for the quarter ending 31 Dec 2025 was 29,019,000, a 36% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

ENANTA PHARMACEUTICALS INC Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 29,019,000 +7,686,000 +36% 31 Dec 2025 10-Q 11 Feb 2026 2026 Q1
Q3 2025 21,387,000 0 0% 30 Sep 2025 10-K 19 Nov 2025 2025 FY
Q2 2025 21,378,000 +196,000 +0.92% 30 Jun 2025 10-Q 13 Aug 2025 2025 Q3
Q1 2025 21,377,000 +198,000 +0.94% 31 Mar 2025 10-Q 14 May 2025 2025 Q2
Q4 2024 21,333,000 +177,000 +0.84% 31 Dec 2024 10-Q 12 Feb 2025 2024 Q1
Q3 2024 21,387,000 +328,000 +1.6% 30 Sep 2024 10-Q 11 Feb 2026 2026 Q1
Q2 2024 21,182,000 +126,000 +0.6% 30 Jun 2024 10-Q 07 Aug 2024 2024 Q3
Q1 2024 21,179,000 +130,000 +0.62% 31 Mar 2024 10-Q 08 May 2024 2024 Q2
Q4 2023 21,156,000 +272,000 +1.3% 31 Dec 2023 10-Q 08 Feb 2024 2024 Q1
Q3 2023 21,059,000 +268,000 +1.3% 30 Sep 2023 10-K 27 Nov 2024 2024 FY
Q2 2023 21,056,000 +336,000 +1.6% 30 Jun 2023 10-Q 08 Aug 2023 2023 Q3
Q1 2023 21,049,000 +431,000 +2.1% 31 Mar 2023 10-Q 09 May 2023 2023 Q2
Q4 2022 20,884,000 +378,000 +1.8% 31 Dec 2022 10-Q 08 Feb 2023 2023 Q1
Q3 2022 20,791,000 +553,000 +2.7% 30 Sep 2022 10-K 22 Nov 2023 2023 FY
Q2 2022 20,720,000 +509,000 +2.5% 30 Jun 2022 10-Q 08 Aug 2022 2022 Q3
Q1 2022 20,618,000 +433,000 +2.1% 31 Mar 2022 10-Q 09 May 2022 2022 Q2
Q4 2021 20,506,000 +364,000 +1.8% 31 Dec 2021 10-Q 10 Feb 2022 2022 Q1
Q3 2021 20,238,000 +161,000 +0.8% 30 Sep 2021 10-K 23 Nov 2022 2022 FY
Q2 2021 20,211,000 +141,000 +0.7% 30 Jun 2021 10-Q 09 Aug 2021 2021 Q3
Q1 2021 20,185,000 +199,000 +1% 31 Mar 2021 10-Q 10 May 2021 2021 Q2
Q4 2020 20,142,000 +332,000 +1.7% 31 Dec 2020 10-Q 09 Feb 2021 2021 Q1
Q3 2020 20,077,000 +374,000 +1.9% 30 Sep 2020 10-K 24 Nov 2021 2021 FY
Q2 2020 20,070,000 +388,000 +2% 30 Jun 2020 10-Q 10 Aug 2020 2020 Q3
Q1 2020 19,986,000 +317,000 +1.6% 31 Mar 2020 10-Q 11 May 2020 2020 Q2
Q4 2019 19,810,000 +375,000 +1.9% 31 Dec 2019 10-Q 10 Feb 2020 2020 Q1
Q3 2019 19,703,000 +308,000 +1.6% 30 Sep 2019 10-K 25 Nov 2020 2020 FY
Q2 2019 19,682,000 +322,000 +1.7% 30 Jun 2019 10-Q 09 Aug 2019 2019 Q3
Q1 2019 19,669,000 +409,000 +2.1% 31 Mar 2019 10-Q 10 May 2019 2019 Q2
Q4 2018 19,435,000 +285,000 +1.5% 31 Dec 2018 10-Q 08 Feb 2019 2019 Q1
Q3 2018 19,395,000 +275,000 +1.4% 30 Sep 2018 10-K 27 Nov 2019 2019 FY
Q2 2018 19,360,000 +270,000 +1.4% 30 Jun 2018 10-Q 09 Aug 2018 2018 Q3
Q1 2018 19,260,000 +206,000 +1.1% 31 Mar 2018 10-Q 10 May 2018 2018 Q2
Q4 2017 19,150,000 +110,000 +0.58% 31 Dec 2017 10-Q 09 Feb 2018 2018 Q1
Q3 2017 19,120,000 +84,000 +0.44% 30 Sep 2017 10-K 29 Nov 2018 2018 FY
Q2 2017 19,090,000 +54,237 +0.28% 30 Jun 2017 10-Q 09 Aug 2017 2017 Q3
Q1 2017 19,054,000 +97,398 +0.51% 31 Mar 2017 10-Q 10 May 2017 2017 Q2
Q4 2016 19,040,000 +244,886 +1.3% 31 Dec 2016 10-Q 09 Feb 2017 2017 Q1
Q3 2016 19,036,000 +319,166 +1.7% 30 Sep 2016 10-K 11 Dec 2017 2017 FY
Q2 2016 19,035,763 +327,829 +1.8% 30 Jun 2016 10-Q 09 Aug 2016 2016 Q3
Q1 2016 18,956,602 +266,207 +1.4% 31 Mar 2016 10-Q 10 May 2016 2016 Q2
Q4 2015 18,795,114 +181,885 +0.98% 31 Dec 2015 10-Q 09 Feb 2016 2016 Q1
Q3 2015 18,716,834 +122,260 +0.66% 30 Sep 2015 10-K 09 Dec 2016 2016 FY
Q2 2015 18,707,934 +127,214 +0.68% 30 Jun 2015 10-Q 10 Aug 2015 2015 Q3
Q1 2015 18,690,395 +212,762 +1.2% 31 Mar 2015 10-Q 08 May 2015 2015 Q2
Q4 2014 18,613,229 +647,300 +3.6% 31 Dec 2014 10-Q 06 Feb 2015 2015 Q1
Q3 2014 18,594,574 +664,793 +3.7% 30 Sep 2014 10-K 11 Dec 2015 2015 FY
Q2 2014 18,580,720 +754,660 +4.2% 30 Jun 2014 10-Q 12 Aug 2014 2014 Q3
Q1 2014 18,477,633 +658,837 +3.7% 31 Mar 2014 10-Q 12 May 2014 2014 Q2
Q4 2013 17,965,929 31 Dec 2013 10-Q 13 Feb 2014 2014 Q1
Q3 2013 17,929,781 +16,795,450 +1481% 30 Sep 2013 10-K 11 Dec 2014 2014 FY
Q2 2013 17,826,060 30 Jun 2013 10-Q 12 Aug 2013 2013 Q3
Q1 2013 17,818,796 31 Mar 2013 10-Q 15 May 2013 2013 Q2
Q3 2012 1,134,331 30 Sep 2012 10-K 18 Dec 2013 2013 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.